Drug Utilization Review Board
Meeting Agenda
Thursday, November 13, 2025
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Review and Approval of Minutes
c) Housekeeping - Luis Moreno, PharmD
2) Prior Authorization Updates- Luis Moreno, PharmD
3) Public Comment
4) Review New Prior Authorization Criteria
a) Avsola (infliximab-axxq) and Biosimilars - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Enbrel (etanercept) - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
c) Humira (adalimumab) and Biosimilars - Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
d) Otezla (apremilast)- Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
e) Pyzchiva (ustekinumab-ttwe) and Biosimilars - Skylar Fenton, PharmD
i) Committee Discussion/Questions
ii) Committee Action
f) Taltz (ixekizumab) - Skylar Fenton, PharmD
i) Committee Discussion/Questions
ii) Committee Action
g) Non-preferred Immunomodulators - Iris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
5) Next Meeting
a) Date: December 11, 2025
b) Topic: New Prior Authorization Reviews
6) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#